Ocular Therapeutix (OCUL) Gross Profit (2014 - 2026)
Ocular Therapeutix's quarterly Gross Profit came in at $9.5 million in Q1 2026, up 374.09% year-on-year from $2.0 million in Q1 2025, and up 3127.3% quarter-over-quarter from $293000.0 in Q4 2025.
Ocular Therapeutix has reported Gross Profit for 13 years, with the latest figure at $9.5 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 374.09% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at $34.0 million (up 5.74% YoY), and the FY2025 full-year result was -$2.0 million, down 103.39% from the prior year.
- Gross Profit for Q1 2026 stood at $9.5 million, up from $293000.0 in the prior quarter.
- The five-year high for Gross Profit was $15.9 million in Q4 2024, with the low at -$21.9 million in Q4 2023.
- Average Gross Profit over 5 years is $6.5 million, with a median of $9.5 million recorded in 2026.
- Year-over-year, Gross Profit soared 654.3% in 2022 and plunged 267.29% in 2023.
- Tracing OCUL's Gross Profit over 5 years: stood at $13.1 million in 2022, then sank by 267.29% to -$21.9 million in 2023, then surged by 172.54% to $15.9 million in 2024, then tumbled by 98.15% to $293000.0 in 2025, then jumped by 3127.3% to $9.5 million in 2026.
- The last three Gross Profit figures came in at $9.5 million (Q1 2026), $293000.0 (Q4 2025), and $12.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.46 Mn |
| Mar 31, 2026 | 9.46 Mn |
| Dec 31, 2025 | 293,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Sep 30, 2025 | 12.77 Mn |
| Sep 30, 2025 | 12.77 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | -3.45 Mn |
| Mar 31, 2025 | -3.45 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 14.93 Mn |
| Jun 30, 2024 | 14.93 Mn |
| Mar 31, 2024 | 13.45 Mn |
| Mar 31, 2024 | 13.45 Mn |
| Dec 31, 2023 | -21.85 Mn |
| Dec 31, 2023 | -21.85 Mn |
| Sep 30, 2023 | 5.77 Mn |
| Sep 30, 2023 | 5.77 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 12.16 Mn |
| Mar 31, 2023 | 12.16 Mn |
| Dec 31, 2022 | 13.06 Mn |
| Dec 31, 2022 | 13.06 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Mar 31, 2022 | 4.12 Mn |
| Mar 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Sep 30, 2021 | 10.84 Mn |
| Sep 30, 2021 | 10.84 Mn |
| Jun 30, 2021 | 3.33 Mn |
| Jun 30, 2021 | 3.33 Mn |
| Mar 31, 2021 | -744,000.00 |
| Mar 31, 2021 | -744,000.00 |
| Dec 31, 2020 | 25.07 Mn |
| Dec 31, 2020 | 25.07 Mn |
| Sep 30, 2020 | -644,000.00 |
| Sep 30, 2020 | -644,000.00 |
| Jun 30, 2020 | -4.58 Mn |
| Jun 30, 2020 | -4.58 Mn |
| Mar 31, 2020 | -4.52 Mn |
| Mar 31, 2020 | -4.52 Mn |
| Dec 31, 2019 | 17.28 Mn |
| Dec 31, 2019 | 17.28 Mn |
| Sep 30, 2019 | -5.95 Mn |
| Sep 30, 2019 | -5.95 Mn |
| Jun 30, 2019 | -6.58 Mn |
| Jun 30, 2019 | -6.58 Mn |
| Mar 31, 2019 | -2.86 Mn |
| Mar 31, 2019 | -2.86 Mn |
| Dec 31, 2018 | 387,000.00 |
| Dec 31, 2018 | 387,000.00 |
| Sep 30, 2018 | 383,000.00 |
| Sep 30, 2018 | 383,000.00 |
| Jun 30, 2018 | -219,000.00 |
| Jun 30, 2018 | -219,000.00 |
| Mar 31, 2018 | -377,000.00 |
| Mar 31, 2018 | -377,000.00 |
| Dec 31, 2017 | -416,000.00 |
| Dec 31, 2017 | -416,000.00 |
| Sep 30, 2017 | -2.72 Mn |
| Sep 30, 2017 | -2.72 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Mar 31, 2017 | -5.55 Mn |
| Mar 31, 2017 | -5.55 Mn |
| Dec 31, 2016 | -5.87 Mn |
| Dec 31, 2016 | -5.87 Mn |
| Sep 30, 2016 | 365,000.00 |
| Sep 30, 2016 | 365,000.00 |
| Jun 30, 2016 | 336,000.00 |
| Jun 30, 2016 | 336,000.00 |
| Mar 31, 2016 | 317,000.00 |
| Mar 31, 2016 | 317,000.00 |
| Dec 31, 2015 | -3.23 Mn |
| Dec 31, 2015 | -3.23 Mn |
| Sep 30, 2015 | -50,000.00 |
| Sep 30, 2015 | -50,000.00 |
| Jun 30, 2015 | -582,000.00 |
| Jun 30, 2015 | -582,000.00 |
| Mar 31, 2015 | 182,000.00 |
| Mar 31, 2015 | 182,000.00 |
| Dec 31, 2014 | -1.42 Mn |
| Dec 31, 2014 | -1.42 Mn |
| Sep 30, 2014 | 111,000.00 |
| Sep 30, 2014 | 111,000.00 |
| Jun 30, 2014 | 77,000.00 |
| Jun 30, 2014 | 77,000.00 |
| Mar 31, 2014 | -283,000.00 |
| Mar 31, 2014 | -283,000.00 |